Cancer’s Metabolic Fuel
Cancer cells depend on small molecules called polyamines to drive their growth and establish an immune privilege shield. Our therapy inhibits polyamine metabolism—shutting down this fuel source.
Cutting off the
Supply Chain
Our Blockade strategy inhibits both the production and import of polyamines in tumors – starving the cancer cells and activating the immune response.
Designed for Synergy
and Precision
Our therapy selectively targets tumors, lowers the polyamine shield and empowers immune checkpoint inhibitors even in resistant cancers. We are turning decades of academic research into real clinical potential.
© 2025 PolyBloc Therapeutics, Inc.™